Cargando…

Cholecalciferol supplementation effectively improved tertiary hyperparathyroidism, FGF23 resistance and lowered coronary calcification score: a prospective study

INTRODUCTION: Tertiary hyperparathyroidism (THPT) and vitamin D deficiency are commonly seen in kidney transplant recipients, which may result in persistently elevated fibroblast growth factor 23 (FGF23) level after transplantation and decreased graft survival. The aim of this study is to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Shu-Meng, Bai, Yang-Juan, Li, Ya-Mei, Tao, Ye, Wang, Xian-Ding, Lin, Tao, Wang, Lan-Lan, Shi, Yun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346334/ https://www.ncbi.nlm.nih.gov/pubmed/35904219 http://dx.doi.org/10.1530/EC-22-0123

Ejemplares similares

FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
por: Ozkok, Abdullah, et al.
Publicado: (2013)

Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism
por: Fořtová, Magdaléna, et al.
Publicado: (2021)

Excessive cholecalciferol supplementation increases kidney dysfunction associated with intrarenal artery calcification in obese insulin-resistant mice
por: Almeida, Youri E., et al.
Publicado: (2020)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
por: Smelt, Hendrika J.M., et al.
Publicado: (2019)

Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
por: Lindberg, Karolina, et al.
Publicado: (2013)

Cholecalciferol supplementation and angiogenic markers in chronic kidney disease
por: Kaur, Jaskiran, et al.
Publicado: (2022)

Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model
por: Nagata, Yuki, et al.
Publicado: (2022)

Fortified phosphorus-lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease
por: Jiang, Jie, et al.
Publicado: (2020)

Myocardial Calcification due to Uncontrolled Hyperparathyroidism
por: Seo, Kyoung-Woo, et al.
Publicado: (2018)

A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis
por: Bansal, Beena, et al.
Publicado: (2014)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients
por: Zheng, Cai-Mei, et al.
Publicado: (2018)

Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
por: Sykała, Monika, et al.
Publicado: (2021)

Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho axis
por: Wei, Xu, et al.
Publicado: (2021)

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
por: Takashi, Yuichi, et al.
Publicado: (2022)

Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats
por: Raya, Ana I., et al.
Publicado: (2016)

The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease
por: Chen, Yan, et al.
Publicado: (2021)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients
por: Zheng, Jing-Quan, et al.
Publicado: (2016)

Oral Postdialysis Cholecalciferol Supplementation in Patients on Maintenance Hemodialysis: A Dose-Response Approach
por: Descombes, Eric, et al.
Publicado: (2014)

Response to Antenatal Cholecalciferol Supplementation Is Associated With Common Vitamin D–Related Genetic Variants
por: Moon, Rebecca J., et al.
Publicado: (2017)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
por: Fassio, Angelo, et al.
Publicado: (2022)

Effects of vitamin D supplementation on FGF23: a randomized-controlled trial
por: Trummer, Christian, et al.
Publicado: (2018)

High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification
por: Fu, Xiao, et al.
Publicado: (2015)

FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study
por: Braithwaite, Vickie, et al.
Publicado: (2012)

Advances in the treatment of secondary and tertiary hyperparathyroidism
por: Zhang, Li-Xi, et al.
Publicado: (2022)

Evaluation of Serum Level of FGF23 and 1,25(OH)(2)D(3) in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy
por: Hassani, Solmaz, et al.
Publicado: (2020)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report
por: Cupisti, Adamasco, et al.
Publicado: (2015)

Effect of Cholecalciferol Supplementation on Bone Turnover Markers in Children and Adolescents With Type 1 Diabetes Mellitus
por: Pankiv, Volodymyr I, et al.
Publicado: (2021)

Prospective effects of cholecalciferol supplementation on irisin levels in sedentary postmenopausal women: A pilot study
por: Dell Aquila, Luiz Phellipe, et al.
Publicado: (2023)

Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
por: Yoshida, Shunsuke, et al.
Publicado: (2023)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

FGF23 promotes prostate cancer progression
por: Feng, Shu, et al.
Publicado: (2015)

Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism
por: Ho, Tzung-Yo, et al.
Publicado: (2019)

Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with Nephropathy
por: Huang, Yan, et al.
Publicado: (2012)

Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol
por: Wylon, Katharina, et al.
Publicado: (2017)

Assessment of Physical Fitness after Bariatric Surgery and Its Association with Protein Intake and Type of Cholecalciferol Supplementation
por: Smelt, Hendrika J. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_18lbg3ekb5606oe4keqnk1qgk7